|
ALGS Aligos Therapeutics Inc 1799448 |
| Balance Sheet |
|
Current Assets
|
$59,629,000.00 |
|
Assets
|
$64,558,000.00 |
|
Current Liabilities
|
$23,322,000.00 |
|
Liabilities
|
$32,769,000.00 |
|
Equity
|
$31,789,000.00 |
|
Shares Out
|
6188186.00 |
| Cash Flow Statement |
|
Operating Cash Flow
|
$-23,128,000.00 |
|
Investing Cash Flow
|
$34,931,000.00 |
| Market Analysis |
Market Cap
|
$26,732,963.52 |
|
Price
|
$4.45 |
|
BVPS
|
5.14 |
|
PB
|
0.84 |
|
EPS
|
-2.21 |
|
PS
|
3.06 |
|
FCF
|
$-23,258,000.00 |
|
| Dividends |
|
Dividend Data Last Updated
|
2026-08-01 09:31:41 |
|
|
| Earnings |
|
Earnings Last Updated
|
2026-08-03 10:01:41 |
|
| Apr |
May |
Jun |
| 2026-03-05 |
-1.91 |
|
|
2026-05-07 |
-2.21 |
|
| Jul |
Aug |
Sep |
|
|
|
|
2025-08-06 |
-1.53 |
|
| Oct |
Nov |
Dec |
|
|
|
|
2025-11-06 |
-3.04 |
|
|
Find a discrepancy? The most accurate way to find company fundamental data is to view ALGS documents filed with the SEC.
ALGS Filings
Clear
